Tuesday, October 18, 2022 from 3:00 PM to 4:30 PM PDT at Continental Ballroom 4
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-189-L01-P
Activity Type: An Application-Based Activity
The goal of this session is to describe the historical context and benefits and risk of using race corrections, including two examples of how race corrections are currently being used and the evidence to support the use. The session will also describe best practices for discussing race corrections with patients when applicable.
 | Moderator: Rebecca Cope, Pharm.D., MPH
Associate Professor of Pharmacy Practice
Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University
View Biography |
Learning Objectives
1. Define race-based medicine and summarize the historical context and rationale for the use of race in medicine.
2. Describe the benefits and risks of using race-based clinical algorithms.
3. Use best practices for relaying information and involving the patient in decision-making processes related to race, ethnicity, or precision medicine.
4. Describe the guidelines, evidence, and rationale outlining the use of race-based algorithms in cardiovascular medicine.
5. Illustrate the appropriate use of race-based data and clinical guideline recommendations for cardiovascular disease states.
6. Describe the controversies around the use of race-based medicine in cardiovascular medicine and implications for clinical practice.
7. Describe the guidelines, evidence, and rationale outlining the use of race-based algorithms in kidney diseases.
8. Illustrate the appropriate use of race-based data and clinical guideline recommendations for kidney diseases.
9. Describe the controversies around the use of race-based medicine in kidney diseases and implications for clinical practice.